Carl A Gold1, Brian J Scott1, Yingjie Weng2, Eric Bernier3, Kathryn A Kvam1. 1. Department of Neurology & Neurological Sciences, Stanford University, Stanford, CA, USA. 2. Stanford University, Quantitative Sciences Unit, Stanford, CA, USA. 3. Stanford Health Care, Stanford, CA, USA.
Abstract
Background and Purpose: The purpose is to determine the impact of an academic neurohospitalist service on clinical outcomes. Methods: We performed a retrospective, quasi-experimental study of patients discharged from the general neurology service before (August 2010-July 2014) and after implementation of a full-time neurohospitalist service (August 2016-July 2018) compared to a control group of stroke patients. Primary outcomes were length of stay and 30-day readmission. Using the difference-in-difference approach, the impact of introducing a neurohospitalist service compared to controls was assessed with adjustment of patients' characteristics. Secondary outcomes included mortality, in-hospital complications, and cost. Results: There were 2706 neurology admissions (1648 general; 1058 stroke) over the study period. The neurohospitalist service was associated with a trend in reduced 30-day readmissions (ratio of ORs: .52 [.27, .98], P = .088), while length of stay was not incrementally changed in the difference-in-difference model (-.3 [-.7, .1], P = .18). However, descriptive results demonstrated a significant reduction in mean adjusted LOS of .7 days (4.5 to 3.8 days, P < .001) and a trend toward reduced readmissions (8.9% to 7.6%, P = .42) in the post-neurohospitalist cohort despite a significant increase in patient complexity, shift to higher acuity diagnoses, more emergent admissions, and near quadrupling of observation status patients. Mortality and in-hospital complications remained low, patient satisfaction was stable, and cost was not incrementally changed in the post-neurohospitalist cohort. Conclusions: Implementation of a neurohospitalist service at an academic medical center is feasible and associated with a significant increase in patient complexity and acuity and a trend toward reduced readmissions.
Background and Purpose: The purpose is to determine the impact of an academic neurohospitalist service on clinical outcomes. Methods: We performed a retrospective, quasi-experimental study of patients discharged from the general neurology service before (August 2010-July 2014) and after implementation of a full-time neurohospitalist service (August 2016-July 2018) compared to a control group of stroke patients. Primary outcomes were length of stay and 30-day readmission. Using the difference-in-difference approach, the impact of introducing a neurohospitalist service compared to controls was assessed with adjustment of patients' characteristics. Secondary outcomes included mortality, in-hospital complications, and cost. Results: There were 2706 neurology admissions (1648 general; 1058 stroke) over the study period. The neurohospitalist service was associated with a trend in reduced 30-day readmissions (ratio of ORs: .52 [.27, .98], P = .088), while length of stay was not incrementally changed in the difference-in-difference model (-.3 [-.7, .1], P = .18). However, descriptive results demonstrated a significant reduction in mean adjusted LOS of .7 days (4.5 to 3.8 days, P < .001) and a trend toward reduced readmissions (8.9% to 7.6%, P = .42) in the post-neurohospitalist cohort despite a significant increase in patient complexity, shift to higher acuity diagnoses, more emergent admissions, and near quadrupling of observation status patients. Mortality and in-hospital complications remained low, patient satisfaction was stable, and cost was not incrementally changed in the post-neurohospitalist cohort. Conclusions: Implementation of a neurohospitalist service at an academic medical center is feasible and associated with a significant increase in patient complexity and acuity and a trend toward reduced readmissions.
Authors: Jennifer P Stevens; David J Nyweide; Sha Maresh; Laura A Hatfield; Michael D Howell; Bruce E Landon Journal: JAMA Intern Med Date: 2017-12-01 Impact factor: 21.873
Authors: Jeffrey H Silber; Lisa M Bellini; Judy A Shea; Sanjay V Desai; David F Dinges; Mathias Basner; Orit Even-Shoshan; Alexander S Hill; Lauren L Hochman; Joel T Katz; Richard N Ross; David M Shade; Dylan S Small; Alice L Sternberg; James Tonascia; Kevin G Volpp; David A Asch Journal: N Engl J Med Date: 2019-03-07 Impact factor: 91.245